Format

Send to

Choose Destination
See comment in PubMed Commons below
Semin Dial. 2013 Sep-Oct;26(5):543-5. doi: 10.1111/sdi.12108. Epub 2013 Jun 14.

How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: Adjuvant therapies to reduce erythropoiesis-stimulating agent dose requirements.

Author information

1
Division of Kidney Diseases and Hypertension, Department of Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Hofstra North Shore-LlJ School of Medicine, Great Neck, New York.
PMID:
23763709
DOI:
10.1111/sdi.12108
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center